Source:http://linkedlifedata.com/resource/pubmed/id/11604159
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2001-10-17
|
pubmed:abstractText |
Neutral glycosphingolipids (GSLs) are considered activation markers on human lymphocytes, which are fundamental for studying the immune system. For cattle, only a limited number of activation markers has yet been identified. We recently showed that Shiga toxin 1, known to use globotriaosylceramide (Gb(3) syn. CD77) as a cellular receptor, depresses proliferation of activated bovine lymphocytes [Infect. Immunol. 67 (1999b) 2209]. In order to confirm the expression of Gb(3)/CD77 on bovine lymphocytes, we flowcytometrically examined a bovine B-lymphoma cell line (BL-3) and bovine peripheral blood mononuclear cells (PBMC) before and after mitogenic stimulation and biochemically characterized neutral GSLs extracted from PBMC. CD77 was detected on the surface of BL-3 cells and cultured PBMC essentially after mitogenic stimulation. Although expressed by all PBMC subpopulations identified, the portion of CD7+ cells was highest for BoCD8+ cells, followed by B-cells and BoCD4+ cells at day 4 of cultivation. Ceramide trihexoside of stimulated PBMC was structurally determined as Gal(alpha1-4)Gal(1-4)Glc(1-1)ceramide (Gb(3)). Biochemically, Gb(3) was also detected within unstimulated PBMC which contained ceramide monohexoside (CMH) and Gb(3) in a ratio of about 4:1. However, stimulation induced an increase of CMH and Gb(3) by a factor of 2.5 and 10, respectively, implicating that bovine lymphocytes regulate surface expression of Gb(3)/CD77 predominantly by quantitative changes in the Gb(3) metabolism. This report presents Gb(3)/CD77 as the first GSL identified on bovine immune cells and highly recommends this activation dependent antigen as a useful tool to investigate lymphocyte activation within the bovine immune system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0165-2427
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19-36
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11604159-Animals,
pubmed-meshheading:11604159-B-Lymphocytes,
pubmed-meshheading:11604159-Cattle,
pubmed-meshheading:11604159-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:11604159-Flow Cytometry,
pubmed-meshheading:11604159-Gas Chromatography-Mass Spectrometry,
pubmed-meshheading:11604159-Gene Expression Regulation,
pubmed-meshheading:11604159-Immunohistochemistry,
pubmed-meshheading:11604159-Leukocytes, Mononuclear,
pubmed-meshheading:11604159-Lymphocyte Activation,
pubmed-meshheading:11604159-Trihexosylceramides,
pubmed-meshheading:11604159-Tumor Cells, Cultured
|
pubmed:year |
2001
|
pubmed:articleTitle |
Globotriaosylceramide (Gb(3)/CD77) is synthesized and surface expressed by bovine lymphocytes upon activation in vitro.
|
pubmed:affiliation |
Faculty of Veterinary Medicine, Institute for Hygiene and Infectious Diseases of Animals, Justus-Liebig-University, Frankfurter Str. 89-91, D-35392 Giessen, Germany. christian.menge@vetmed.uni-giessen.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|